STAT3在肿瘤中的作用研究进展
被引量:3
Research Progress in Role of STAT3 in Tumor
摘要
STAT3的异常表达和活化与肿瘤的发生、发展及恶性生物学行为关系密切。全文对STAT3在细胞中的作用和临床应用作一综述。
出处
《肿瘤学杂志》
CAS
2009年第8期766-768,共3页
Journal of Chinese Oncology
参考文献21
-
1Yu H, Jove R. The STATs of cancer-new molecular targets come of age[J]. Nat Rev Cancer, 2004, 4(2):97-105.
-
2Darnell JE Jr.Transcription factors as targets for cancer therapy[J]. Nat Rev Cancer, 2002, 2(10):740-749.
-
3Schindler CW. Series introduction. JAK-STAT signaling in human disease[J]. J Clin Invest, 2002, 109(9):1133-1137.
-
4Zhang Y, Turkson J, Carter-Su C, et al. Activation of STAT3 in v-Src-transformed fibroblasts requires cooperation of Jakl kinase activity [J]. J Biol Chem, 2000, 275 (32):24935-24944.
-
5Kisseleva T, Bhattacharya S, Braunstein J, et al. Signaling through the JAK/STAT pathway, recent advances and future challenges[J]. Gene, 2002, 285(1-2): 1-24.
-
6Niu G, Wright KL, Huang M, et al. Constitutive STAT3 activity up-regulates VEGF expression and tumor angiogenesis[J]. Oncogene, 2002, 21(13) :2000-2008.
-
7Bromberg JF, Wrzeszczvnska MH, Devgan G, et al. STAT3 as an oncongene[J]. Cell, 1999, 98(3):295-303.
-
8Bowman T, Garcia R, Turkson J, et al. STATs in oncogenesis[J]. Oncogene, 2000, 19 (21):2474-2488.
-
9Alvarez JV, Febbo PG, Ramaswamy S, et al. Identification of a genetic signature of activated signal transducer and activator of transcription 3 in human tumors [J]. Cancer Res, 2005, 65(12):5054-5062.
-
10Dauer D J, Ferraro B, Song L, et al. STAT3 regulates genes common to both wound healing and cancer [J]. Oncogene, 2005, 24(21):3397-3408.
同被引文献24
-
1Deng-Fu Yao, Xin-Hua Wu, Yong Zhu, Gong-Sheng Shi, Zhi-Zhen Dong, Deng-Bing Yao, Wei Wu, Li-Wei Qiu and Xian-Yong Meng Nantong, China Research Center of Clinical Molecular Biology , Department of Pathology and Department of Gastroenterology , Affiliated Hos- pital of Nantong University,Department of Diagnostics , and Institute of Neurosciences , Nantong University,Nantong 226001, China.Quantitative analysis of vascular endothelial growth factor, microvascular density and their clinicopathologic features in human hepatocellular carcinoma[J].Hepatobiliary & Pancreatic Diseases International,2005,4(2):220-226. 被引量:81
-
2温韬,钱海利,谢立,贺立香,黄德庄.肝癌患者血管内皮生长因子、内皮素和一氧化氮的水平变化及其意义[J].中华肝脏病杂志,2004,12(7):441-441. 被引量:7
-
3谢一利,楼丽广.表皮生长因子受体信号通路及其靶向肿瘤治疗[J].国外医学(肿瘤学分册),2005,32(5):361-364. 被引量:8
-
4Kim ES,Hirsh V,Mok T,et al.Gefitinib versus docetaxel in previously treated non-small-cell lung cancer INTEREST:randomised phase Ⅲ trial[J].Lancet,2008,372 (9652):1809-1818.
-
5Raben D,Bianco C,Milas L,et al.Targeted therapies and radiation treatment of head and neck cancer:are we making progress[J].Semin in Radiat Oncol,2004,14(2):139-152.
-
6Chua DT,Nicholls JM,Sham JS,et al.Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy[J].Int J Radiat Oncol Biol Phys,2004,59(1):11-20.
-
7陈永杰,付艳忠,赵志华.原发性肝癌组织中血管内皮生长因子、微血管密度检测[J].郑州大学学报(医学版),2007,42(5):925-927. 被引量:9
-
8Bareschino MA, Schettino C, Rossi A,et al.Treatment ad- vanced non small cell lung cancer[J ].J Thoeac Dis,2011,3 (2): 122-133.
-
9Gridelli C, Maione P, Rossi A, et al.Pemetrexed in advanced non small cell lung cancer[J ].Expert Opin Drug Saf, 2011, 10(2) :311-317.
-
10Spitzner M,Roesler B,Bielfeld C,et al.STAT3 inhibition sensitizes colorectal cancer to chemoradiotherapy in vitro and in vivo[J].International Journal of Cancer,2014,134 (4) :997-1007.
引证文献3
-
1王艳萍,孟大为,暴继敏,马云鹏,李哲.吉非替尼联合紫杉醇对鼻咽癌HNE1细胞EGFR、STAT3蛋白磷酸化的影响及意义[J].山东医药,2010,50(23):46-47. 被引量:2
-
2温翔,王家宏.VEGF和STAT-3在肝癌中的研究进展[J].包头医学院学报,2013,29(5):123-126.
-
3许冠华,雷俊华,金丽莎,陈喆.隐丹参酮联合顺铂作用于非小细胞肺癌PC9细胞的体外研究[J].浙江中西医结合杂志,2014,24(12):1043-1045. 被引量:9
二级引证文献11
-
1王利.表皮生长因子受体抑制剂吉非替尼的研究进展[J].安徽医学,2015,36(1):111-114. 被引量:10
-
2侯雪华,冯正权.中医药抑制STAT3抗肿瘤的研究进展[J].江西中医药大学学报,2015,27(5):116-119. 被引量:1
-
3朱业靖.丹参酮对晚期非小细胞肺癌患者凝血指标与临床效果的影响研究[J].中国医药指南,2016,14(6):1-3. 被引量:3
-
4刘兴贵,刘丹丽.益气活血类中药治疗肺癌的实验研究进展[J].黑龙江中医药,2015,44(6):70-72. 被引量:1
-
5许冠华,金柏军,雷俊华.丹参及丹参提取物增敏放疗的研究进展[J].浙江中西医结合杂志,2016,26(8):770-772. 被引量:6
-
6李哲,刘树佳,陈进杰,赵毅,翁玉玲.熟地黄多糖治疗鼻咽癌对其STAT3通路相关生化指标的影响[J].现代肿瘤医学,2018,26(5):685-690. 被引量:5
-
7刘磊,张光霁,楼招欢,徐浩.丹参有效成分防治恶性肿瘤作用机制的研究进展[J].中华中医药杂志,2018,33(6):2472-2475. 被引量:31
-
8许冠华,沈丽君,刘红胜,吴逢选,王云超.隐丹参酮对荷瘤小鼠化疗后免疫功能低下的影响[J].浙江临床医学,2018,20(9):1488-1489. 被引量:3
-
9许冠华,刘红胜,王云超,雷俊华,沈利君.隐丹参酮对顺铂化疗后荷瘤小鼠肝肾功能的保护作用[J].中华危重症医学杂志(电子版),2019,12(1):50-52.
-
10汤姝,吴占申,李纳,温强,康建,张晓坚.基于网络药理学探讨隐丹参酮抗非小细胞肺癌的作用机制[J].中国药理学通报,2022,38(1):119-125. 被引量:4
-
1黄昌杰,湛永滋,黄剑峰,王湘萍.异长春花碱与顺铂联合治疗36例晚期非小细胞肺癌[J].肿瘤学杂志,2002,8(2):103-104. 被引量:2
-
2李娟,刘益清.人大肠腺癌中MMP-9与bFGF的表达及意义[J].现代肿瘤医学,2006,14(10):1241-1243.
-
3何忠良,周红艳,章华丽.缺氧诱导因子-1α在胃癌组织中的表达及其与胃癌侵袭性的关系[J].临床内科杂志,2010,27(10):693-694. 被引量:1
-
4王晓辉.Wnt信号通路与乳腺癌[J].中国肿瘤,2006,15(11):768-771. 被引量:11
-
5王亚东,杨留才.直肠癌PCNA与p53蛋白的表达及临床意义研究[J].结直肠肛门外科,2013,19(1):1-4.